Skip to content
WeighLab
Menu
Ranked #393 · Grade C

Vyora Wellness review

Vyora Wellness offers compounded semaglutide ($299/mo) and compounded tirzepatide ($399/mo) as 4-week subscription plans.

Visit Vyora Wellness Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$299/mo (compounded)
Tirzepatide
$399/mo (compounded)
Coverage
Coverage not published
Brand-name
Compounded only

Semaglutide · modeled / year

$3,588

Tirzepatide · modeled / year

$4,788

The Index scorecard

Vyora Wellness scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month47/100
Price Transparency38/100
Nationwide Access24/100
Formulation Options66/100
Clinical Oversight79/100
Contract Flexibility55/100

Where the value is

  • LegitScript certified
  • Price includes nutritional guidance, 24/7 coaching, and community access
  • Both semaglutide and tirzepatide available
  • BMI 25+ eligibility threshold (lower than some competitors)

The tradeoffs

  • State availability not publicly disclosed
  • Pricing is above average ($299–$399/mo) compared to competitors
  • Compounded only — no brand-name options
  • Broader platform (metabolic, longevity, topical products)

The bottom line

Best for: Patients wanting coaching-inclusive compounded GLP-1 programs. Vyora Wellness offers compounded semaglutide ($299/mo) and compounded tirzepatide ($399/mo) as 4-week subscription plans.

Ranked #393 of 492 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 491 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Vyora Wellness.

The 21 programs nearest this one

Pricing, states and verification reflect Vyora Wellness's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Vyora Wellness's site. Not medical advice; see our disclosure.

← Back to the value leaderboard